Literature DB >> 16772703

Total parenteral nutrition using continuous intravenous infusion via the posterior vena cava in rats.

Kentaro Asanuma1, Shun-ichiro Komatsu, Takayuki Sakurai, Ryo Takai, Shuichi Chiba.   

Abstract

This study was conducted to evaluate the feasibility of total parenteral nutrition (TPN) in rats using continuous intravenous infusion (tail cuff method) via the posterior vena cava. A catheter was inserted into the posterior vena cava from the femoral vein of 10 females (Experiment 1) and 16 females (Experiment 2). The depth of the inserted catheter from the femoral vein was set at 4.5 cm for Experiment 1 and was set at 6 cm for Experiment 2. The test animals were divided into two groups in each experiment: a 5% D-Mannitol (MAN) group and a TPN group. In Experiment 1, TPN rats showed macroscopic lesions (edema in peritoneum, increased collateral vasculature, induration in perivenous tissue, and thrombus) at the tip of the catheter. The diameter of the posterior vena cava (2.86 +/- 0.16 mm, mean +/- S.D.) was significantly greater than that of the anterior vena cava (2.45 +/- 0.22 mm) in 10 rats of Experiment 1. In Experiment 2, TPN rats showed no abnormalities at necropsy. Our findings suggest that TPN administered via the posterior vena cava in Sprague-Dawley rats requires the catheter to be inserted to a depth of 6 cm from the femoral vein. We hypothesize that this is because it is inserted to the level of the renal vein branch where the diameter of the posterior vena cava may be greatest.

Entities:  

Mesh:

Year:  2006        PMID: 16772703     DOI: 10.2131/jts.31.139

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  1 in total

1.  Stimulation of adrenal chromaffin cell proliferation by hypercalcemia induced by intravenous infusion of calcium gluconate in rats.

Authors:  Kaori Isobe; Tsuneo Ito; Shun-Ichiro Komatsu; Kentaro Asanuma; Etsuko Fujii; Chie Kato; Kenji Adachi; Atsuhiko Kato; Tetsuro Sugimoto; Masami Suzuki
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.